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Modeling the Fluorescence of Protein-Embedded Tryptophans with ab Initio
Multiconfigurational Quantum Chemistry: The Limiting Cases of Parvalbumin and
Monellin
Sara Pistolesi,† Adalgisa Sinicropi,† Rebecca Pogni,† Riccardo Basosi,† Nicolas Ferré,‡ and
Massimo Olivucci*,†,§
Dipartimento di Chimica, UniVersità di Siena, Via Aldo Moro 2, I-53100 Siena, Italy, UMR 6264: Laboratoire
Chimie ProVence, UniVersités d’Aix-Marseille I, II et III-CNRS, Faculté de St-Jérôme Case 521, 13397 Marseille
cedex 20, France, and Chemistry Department, Bowling Green State UniVersity, Bowling Green, Ohio 43403
ReceiVed: August 22, 2009

We show that a quantum-mechanics/molecular-mechanics strategy based on ab initio (i.e., first principle)
multiconfigurational perturbation theory can reproduce the spectral properties of a tryptophan residue embedded
in the contrasting hydrophobic and hydrophilic environments of parvalbumin and monellin, respectively. We
show that the observed absorption and emission energies can be reproduced with a less than 3 kcal mol-1
error. The analysis of the computed emission energies based on a protein disassembly scheme and protein
electrostatic potential mapping allows for a detailed understanding of the factors modulating the tryptophan
emission. It is shown that for monellin, where the tryptophan is exposed to the solvent, the fluorescence
wavelength is controlled not only by the distribution of the point charges of the protein-solvent environment
but also by specific hydrogen bonds and, most important, by the environment-induced change in chromophore
structure. In contrast, in parvalbumin, where the chromophore is embedded in the protein core, the structure
and emission maxima are the same as those of an isolated 3-methylindole fluorophore. Consistently, we find
that in parvalbumin the solvation does not change significantly the computed emission energy.
Introduction
The computer-aided design of unnatural proteins with specific
optical properties, such as color and luminescence, represents
a complex problem. In these cases, the quantum chemical
method employed must be capable to describe both ground and
electronically excited states of the protein chromophore. In
particular, the computational description of a luminescent (e.g.,
fluorescent) protein implies the use of methodologies capable
of predicting the excited state equilibrium structure and reactivity
of fluorophores characterized, even for singlet states, by mixtures
of open-shell and charge transfer characters. The ab initio (i.e.,
first-principle) complete-active-space self-consistent-field (CASSCF) method1 is a multiconfigurational method offering maximum flexibility for an unbiased (i.e., with no empirically derived
parameters and avoiding single-determinant wave functions)
description of the electronic and equilibrium structure of the
ground and excited states of a molecule. Furthermore, the
CASSCF wave function can be readily used for subsequent
multiconfigurational second-order perturbation theory2 computations (CASPT2) of the dynamic correlation energy of each state
ultimately allowing for a quantitative evaluation of energy gap
between different electronic states.3,4
In recent studies5 we have focused on the prediction of the
spectra of proteins featuring cationic or anionic chromophores.
In particular, we have shown that an ab initio CASPT2//
CASSCF quantum chemical procedure (equilibrium geometries
and electronic energies are determined at the CASSCF and
CASPT2 levels, respectively) allows, when used as part of a
* Corresponding author. E-mail: olivucci@unisi.it or molivuc@bgsu.edu.
†
Università di Siena.
‡
UMR 6264: Laboratoire Chimie Provence.
§
Bowling Green State University.

quantum-mechanics/molecular-mechanics (QM/MM) method,
for the evaluation of the excitation energy of the retinal
protonated Schiff base chromophore6 (treated quantum mechanically) of rhodopsin (treated using molecular mechanics force
fields), of the conjugated bases of the para-hydroxy-benzylidene
imidazolone fluorophore7 embedded in the β-barrel scaffold of
the green fluorescent protein, and of the para-hydroxy-cinnamyl
chromophore of the photoactive yellow protein.8 On the other
hand, the simulation of proteins featuring neutral chromophores/
fluorophores has, to our knowledge, never been attempted using
the same technology.
The fluorescence of tryptophan, due to its 3-methylindole (3MIfluor) moiety, is sensitive to the molecular environment.9-13
The 3-MIfluor emission maxima fall in the 308-355 nm14 range,
with the most blue-shifted emissions associated with apolar
environments. For this reason, its fluorescence spectrum and
intensity have been used to gather structural information and
follow protein structural changes such as during folding or
denaturation.15 Due to its spectral properties and wide distribution, tryptophan appears as an ideal candidate for high-level
(i.e., “brute force”) quantum chemical investigation of a proteinembedded neutral fluorophore. Accordingly, one specific goal
of the present study is to gain an atomic-level understanding of
the factors controlling the fluorescence wavelength of simple
proteins containing a single tryptophan residue with respect to
the isolated gas-phase 3-methylindole (3-MIgas). This information
can be used to rationalize/predict quantitatively the fluorescence
of different proteins or protein mutants where a tryptophan probe
has been inserted in certain key positions.16
In the following, we use a CASPT2//CASSCF/AMBER/631G* QM/MM protocol to compute the tryptophan residue
absorption (λamax) and emission (λfmax) maxima values of two
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very different proteins. These are the F102W mutant of carp
parvalbumin17 (Parv), a calcium-binding protein, and monellin18
(Mone), a sweet protein extracted from the African serendipity
berry Dioscoreophyllum cumminsii. While, due to their high
cost, CASPT2//CASSCF/AMBER computations cannot presently be used for screening a large set of proteins, the chosen
proteins represent different limiting cases. In fact, according to
their crystallographic structures, in Parv the single tryptophan
residue is located in a substantially hydrophobic cavity that does
not contain solvent (water) molecules (see left side of Figure
1). In contrast, in Mone, the tryptophan residue is located on
the external surface of the protein in direct contact with the
solvent (see right side of Figure 1). The fact that the observed
value of λfmax of the two proteins differs by <25 nm (<6.5 kcal
mol-1 difference in excitation energy) makes them challenging
candidates for modeling and analysis.
Below we show that, for both Mone and Parv, the computed
λamax and λfmax values reproduce the observed quantities with a
blue-shifted error of <8 nm (equivalent to a e2.5 kcal mol-1
error). These results compare well with those reported for
charged chromophores such as, for instance, the λamax computed
for a set of retinal proteins with a <35 nm (<3.0 kcal mol-1)
blue-shifted error. Notice also that the relative λfmax changes
were reproduced with a <2.0 kcal mol-1 error. Such limited
errors allow for an atomic-level analysis of the strongly redshifted fluorescence of Parv and Mone with respect to 3-MIgas.
Below we demonstrate that in Parv such λfmax change arises
from the stabilization of the 1La emitting state (with respect to
the ground state) due, exclusively, to the anisotropy of the
positiVe electrostatic potential generated by the protein. On the
other hand, the larger λfmax change seen in Mone is due to
different effects including a change in the 3-MIfluor geometry
(accounting for ca. 50% of the observed red-shift with respect
to 3-MIgas) and a positive electrostatic potential imposed,
cooperatively, by the protein residues and average solvent
configuration.
Methods and Models
A full description of our QM/MM protocol and protein model
building is given in the Supporting Information. Briefly, our
QM method is based on a hydrogen link-atom scheme19 with
the frontier placed at the CR-Cβ bond of the Trp102 and Trp3
side chains of Parv and Mone, respectively. The selected
CASSCF active space comprises the full π-system of 3-MIfluor
(ten electrons in nine orbitals). The MM (we use the AMBER
force field) and QM segments interact in the following ways:
(i) the QM electrons and the full set of MM point charges
interact via the one-electron operator, (ii) stretching, bending,
and torsional potentials involving at least one MM atom are
described by the MM potential, and (iii) QM and MM atom
pairs separated by more then two bonds interact via standard
van der Waals potentials. CASSCF/6-31G*/AMBER geometry
optimization is carried out with the GAUSSIAN0320 and
TINKER21 programs.
As detailed below, we define two types of protein models
featuring different levels of approximation. The first (Parv-MD
and Mone-MD) are fully solvated models in which the average
solvent configuration is determined via molecular dynamics
(MD) equilibration (see left side of Scheme 1). The second is
a cruder model that lacks the solvent in Parv (Parv in vacuo)
and features a 3-MIfluor shielding shell of solvent molecules
equilibrated in the absence of the protein (i.e., featuring the
configuration of the pure solvent) in Mone (Mone shell) (see
right side of Scheme 1). Parv in vacuo and Mone shell are
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analytical tools used to help to determine the factors controlling
fluorescence shifts.
The Parv-MD model is based on the F102W mutant and is
derived from monomer A of the crystallographic structure
deposited in the Protein Data Bank (PDB) archive as file 1B8R,17
while model Mone-MD is derived from monomer A deposited
in the PDB archive as file 1IV7.18 To get globally neutral
models, one sodium and two chloride ions have been added to
Parv and Mone, respectively. The average configuration of the
solvent surrounding the proteins has been produced according
to the following protocol: the PDB structures are embedded in
large rectangular boxes (60 × 63 × 53 and 48 × 60 × 53 Å3
equivalent to 3569 and 2623 solvent molecules placed within 8
Å from any given Mone and Parv atom, respectively) of TIP3P
waters that were energy minimized at the MM level for 2000
steps using the steepest descent method and the AMBER force
field. Then, 500 ps MD simulations of the solvent were
performed using the Sander module of the Amber 7.0 package22
with the standard parameters. Both the MM energy minimization
and MD simulation were carried out using periodic boundary
conditions to simulate the solvent bulk. Coordinates coming
from the last frame were used to build the final QM/MM models.
This required a CASSCF/6-31G*/AMBER geometry optimization relaxing the coordinates of the 3MIfluor (the full QM
subsystem) together with those of the TIP3P water molecules
and side chains within 5 Å from any given QM atoms (due to
such threshold, no solvent molecules are optimized for Parv).
The optimizations have been stopped when the maximum force
is <0.003 u.a./bohr and the rms is <0.0005 bohr. The equilibrium
structures for the ground state (S0) and for the first and second
singlet excited states (S1, S2) were calculated. The S0 relaxation
always produces a structure very close to the crystallographic
one. Notice that during the S1 and S2 optimization the side chains
and solvent molecules surrounding the fluorophore may change
position/orientation to adapt to the corresponding excited state
charge distribution of 3-MIfluor. In Mone-MD, the 39 relaxed
solvent molecules interact with the equilibrated fixed outer
solvent configuration. The outer solvent extends 16, 11, and 16
Å away from the closest 3-MIfluor atom along the x, y, and z
directions of the solvent box (corresponding to more than four
layers of water surrounding the fluorophore). In Parv, the solvent
box extends 24, 14, and 17 Å away from the fluorophore located
at the center of the protein matrix. During the QM/MM
calculations, long-range electrostatic effects are not included
beyond the solvent box boundaries. Since the 3-MIfluor fluorophores of Parv-MD and Mone-MD are located in different
regions of the box we cannot exclude different accuracies in
the evaluation of the corresponding excitation energies. Again,
notice that the coordinates of the full protein backbone and side
chains located >5 Å away from the QM atoms are kept fixed at
their crystallographic values (these are considered average
values). Due to the excessive computational cost, no second
derivative computations could be performed to rigorously
determine the nature of the stationary point.
The reduced Parv in vacuo and the Mone shell models are
derived using the crystallographic structures and QM/MM
optimization protocol seen above but feature a different treatment of the solvent environment. Parv in vacuo does not include
the solvent at all. In Mone shell the solvent is represented by a
shell of solvent molecules set up by placing the systems in a
rectangular box of TIP3P water molecules positioned within 8
Å from any given atom of the protein using the xleap module
of the Amber package.22 This module provides an initial
configuration of the solvent corresponding to a snapshot of MD
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SCHEME 1: Type of Models Used for the Construction
of the Ground and Excited State QM/MM Equilibrium
Structures

equilibrated waters in the absence of the solute. To determine
a relaxed solvent configuration, this is then minimized for 2000
steps (including counterions) using the steepest descent method
(without MD equilibration) while keeping the solute fixed. The
resulting configuration provides a solute cavity that, in contrast
with the Mone-MD cavity, is not adapted to the solute point
charges. The final QM/MM model is constructed by discarding
all solvent molecules except those forming a solvent sphere of
8 Å radius centered on the 3MIfluor chromophore. The equilibrium structures for Mone shell is then determined by CASSCF/
6-31G*/AMBER geometry optimization to relax the coordinates
of the QM chromophore as well as the MM residues and water
molecules within 5 Å from any given atom of the 3MIfluor
moiety. The positions of the remaining solvent molecules (in
this model, an ca. 3 Å shield of frozen solvent molecule provides
a cage keeping the solvent shell in the correct position and
density), protein backbone, and distant residues were kept frozen
during QM/MM calculations. We use this model to test the effect
of the correct orientation of the solvent molecules surrounding
the fluorophore.
In all cases, the residue charges are described by the standard
AMBER force field,23 and thus the residue polarizability or/
and dispersion effects are not explicitly treated. As originally
pointed out by Warshel,24,25 a correct QM/MM protein model
should include the solvent and account for the solvent and
protein polarizability. On the other hand, the effect of the residue
polarizability and dispersion on the absolute excitation energy
has been shown to be limited (for bR, Warshel et al.26 estimated
an effect of <1500 cm-1; see also the work by Ren et al.,27
Matsuura et al., and Rajamani et al.28) and shall fall into the
reported error (however, notice that cancellation effects cannot
be excluded). Due to cancellation effects, the error on excitation
energy changes will be even smaller.
In the context of the present work, the prepared Mone-MD
and Parv-MD structures are assumed to provide acceptable
representation of the average environment of the chromophore/
fluorophore (i.e., given the high >40% content of solvent in the
crystalsssee the PDB filesswe assume that the crystallographic
structures provide a suitable protein average structure in solution,
and possible large-amplitude low-frequency fluctuations affecting the average structure are assumed to have a small effect on
the observed λamax and λfmax values). Furthermore, within our
fixed charge model, the excitation energy should be mainly
determined from the residues belonging to the chromophore
cavity. This assumption has been assessed29 by evaluating the
λamax of rhodopsin with a full protein model and with a reduced
protein model consisting of the 27 residues surrounding the
retinal chromophore and two crystallographic waters. It is shown
that the two λamax values differ by <1 kcal mol-1.
For all protein models, at the S0 equilibrium geometries a
CASPT2 computation is carried out, using the MOLCAS-6

Figure 1. Top. View of parvalbumin (left) and monellin (right)
structures. The positions of the 3-methylindole (red) and of the charged
residue of monellin (Lys44) are highlighted. Bottom. Structure of the
3-methylindole (green) fluorophore.

program,30,31 to evaluate the vertical excitation energy for the
(S0fS1 and S0fS2) transitions (assumed to match the energy
of the corresponding λamax values) and the associated oscillator
strength. The emission λfmax values from the first and second
excited states (S1fS0 and S2fS0 transitions) are evaluated by
computing the S1-S0 and S2-S0 vertical energy gaps via
CASPT2 computations using a 0th-order three-root state average
CASSCF wave function at the S1 and S2 equilibrium geometry,
respectively.
Again, notice that while the AMBER charges account for S0
polarization effects in a mean-field way32 no polarizable residue
is included in the protein model. The same charges are used
for the excited state computations without introducing an ad
hoc dielectric constant. Also, notice that, in this work, there is
no scaling of the computed CASPT2//CASSCF/AMBER excitation energies.
Results and Discussion
The changes in the tryptophan fluorescence as a function of
the protein structure are a manifestation of the diversity of
protein environments.15 Since the stiff bicyclic framework of
the 3-MIfluor structure does not allow for significant deconjugation of its π-system, the observed spectral change is expected
to originate mainly from a change in the electrostatic potential
acting on the fluorophore centers. In other words, as pointed
out by Callis and co-workers,14 the λfmax value and intensity
must depend on the “electrostatic potential landscape”. Most
important, also the fluorescence lifetime and its decay dynamics
are affected by such a landscape.13 In this context, the possibility
to employ ab initio (i.e., unbiased) multiconfigurational quantum
chemistry opens up new perspectives. Indeed, in the past,
CASPT2//CASSCF photochemical reaction path computations33
have shown that (nonadiabatic) hydrogen and charge (electron)
transfer mediated by conical intersections provide the main
channel of lifetime modulation (e.g., through fluorescence
quenching) of synthetic fluorophores such as azoalkanes and
ketones.34-36 Thus, the development of CASPT2//CASSCF/
AMBER protocols for the evaluation of excited state reaction
paths6 and trajectories37 should allow for the extension of such
studies to protein fluorophores.
As a preliminary step toward the investigation of the
tryptophan fluorescence and its decay dynamics in proteins with
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TABLE 1: Computed and Observed Absorption Maxima (λmax) and Computed Change in Dipole Moments (∆µ) for the
Vertical Transitions of 3-MIgas, Parv, and Monea
protein model (equilibrium struct.)

a

calcd λmax (nm)

GS-3-MIgas (S0fS1)

277 (103.2) [0.02]

GS-3-MIgas (S0fS2)
1
La-3-MIgas (S2fS0)
GS-Parv-MD (S0fS1)
GS-Parv-MD (S0fS2)
1
La-Parv-MD (S1fS0)
GS-Mone-MD (S0fS1)
GS-Mone-MD (S0fS2)
1
La-Mone-MD (S1fS0)

249
295
279
257
308
279
261
336

(115.0) [0.09]
(97.1) [0.11] 96.98
(102.7) [0.02]
(111.5) [0.08]
(92.9) [0.10] 92.14
(102.7) [0.02]
(109.7) [0.07]
(85.2) [0.09] 84.31

obsd λmax (nm)

∆µ (Debye)

282 (101.3) {6.9}
1
Lb ) [0.045]
1
La ) [0.123]
295 (96.9)
275 (103.9) {5.5}

0.18

316 (90.4)
277 (103.2) {14.7}

5.49
0.56
5.64
5.61

339 (84.3)

2.08
5.85
0.46

-1

Excitation energies (kcal mol ) are given in parentheses. Oscillator strengths are given in square brackets. The change in oscillator
strengths can be compared with the variation in the observed extinction coefficients (10-3 M-1 cm-1) given in curly brackets. The values of
CASPT2//CASSCF/ANO-S (C,N[4s3p1d]/H[2s]) energies, computed at the corresponding CASSCF/6-31G* optimized geometries, are given in
italics. Computed spectral parameter data for the parent gas-phase indole (not reported below) using the same protocol and the (C,N[3s2p1d]/
H[2s]) ANO-S basis are reported in ref 38.

multiconfigurational quantum chemistry tools, here we focus
on the origin of the λfmax value. For other photoactive proteins,
four different molecular factors have been proposed to play a
role at the molecular level: (i) the increased or decreased
conjugation of the π-system;34,35 (ii) the placement of charged,
polarized, or polarizable groups close to the fluorophore unit;36
(iii) the contact with the solvent molecules;39 and (iv) the
chromophore orientation with respect to the protein cavity.5
Factor ii and iii are usually considered dominating.
Past work employing an INDO/S-CIS semiempirical quantum
chemical protocol coupled with the force field CHARMM on
several proteins containing a single tryptophan residue has
shown that it is possible, using a specific scaling factor for the
fluorophore charges, to reproduce systematically the fluorescence
wavelength within a <15 nm error (with respect to the available
experimental data). On the basis of these data, it was proposed
that, in Mone, the λfmax value is controlled by the polarization
of the indole ring by the electric fields of both the solvent (water)
and protein charges, while in Parv, the λfmax is mainly controlled
by the geometrical polarization of the external water molecules.14
However, a quantitative analysis of factors i-iv based on the
results of ab initio multiconfigurational quantum chemistry has
never been reported.
In Table 1, we report the excitation energies, evaluated at
the ground state (S0) equilibrium structure, and the emission
energies, evaluated at the 1La equilibrium structure, for the ParvMD and Mone-MD models together with those of the reference
system 3-MIgas. In their S0 equilibrium geometry, the proteins
display a slightly lower 1Lb state (see the Supporting Information). In contrast, in the 1La excited state geometry, S1 always
corresponds to the 1La state, thus displaying charge transfer
character (i.e., a larger oscillator strength and dipole moment
change). Such 1La/1Lb inversion does not occur in 3-MIgas where
the covalent 1Lb state is always lower (12 kcal mol-1 at GS-3MIgas). The computed emission energies reproduce the observed
values with systematically blue-shifted errors of e2.5 kcal mol-1
(see Figure 2A). The previous (semiempirical) INDO/S-CIS
based study by Callis predicted, for Mone and Parv, red-shifted
λfmax 6.7 and 1.3 kcal mol-1 of the observed values, respectively.
These errors were reduced to 3.0 and 0.7 kcal mol-1 after scaling
of the fluorophore charges. Our unscaled CASPT2//CASSCF/
AMBER QM/MM protocol yields, for the same quantities, 0.9
and 2.4 kcal mol-1 blue-shifted errors, respectively.
As described in the Methods and Models section, Parv in
vacuo and Mone shell are cruder Parv and Mone models. Parv
in vacuo has no solvent. The errors in the predicted λamax and

Figure 2. Analysis of the CASPT2//CASSCF/6-31G*/Amber emission
energies (equilibrium 1La structures) of 3-MIgas, Parv, and Mone models.
(A) Full circles: Parv in vacuo, Mone shell, 3-MIgas (see Methods and
Models). Crossed circles: ANO-S emission energies of 3-MIgas, ParvMD, and Mone-MD. Half open circles: Fully solvated models MoneMD and Parv-MD. Cross: Mone-MD deprived of the solvent bulk
(Mone-MD-shell). Open circles: experimental values. (B) Isolated
chromophores taken with their protein equilibrium geometries. Full
triangles: Parv in vacuo and Mone shell. Half open triangles: ParvMD and Mone-MD. (C) Protein embedded chromophores (i.e., with
removed solvent) taken with the Mone-MD and Parv-MD equilibrium
geometries. Half open squares: Mone-MD and Parv-MD.

λfmax values computed for such a model are similar to the one
found for Parv-MD. This reflects a limited influence of the
solvent on the electronic structure of the protein-embedded
fluorophore. In contrast, the Mone shell model displays a
significantly larger blue-shifted error (4.5 kcal mol-1) with
respect to the values predicted for Mone-MD. Consistently with
the Parv in vacuo model, this effect does not come from the
model lack of solvent bulk. In fact, removal of the solvent bulk
in Mone-MD while keeping a solvent shell of waters within 5
Å from any 3-MIfluor atom generates a model (here indicated as
Mone-MD-shell) that yields an excitation energy that is only 1
kcal mol-1 larger than the fully solvated system (see the MoneMD-shell value in Figure 2A). In other words, a limited solvent
shell with the correct configuration will reproduce most of the
red-shifting solvent effect. The larger λfmax error seen in the
Mone shell is due to a solvent average configuration that is not

16086

J. Phys. Chem. B, Vol. 113, No. 49, 2009

adapted to the solvent-exposed 3-MIfluor and surrounding Mone
charge distribution. In conclusion, the effect of solvent is, as
expected, limited in Parv where the fluorophore is embedded
in a hydrophobic cavity but large (e.g., showing a 3-fold error
increase with respect to the observed λfmax value) in Mone where
the fluorophore is placed at the surface of the protein and in
direct contact with the solvent. In the next section, we will
provide a rationalization for these effects on the basis of the
electrostatic potential acting on the 3-MIfluor centers.
The error coming from the use of the 6-31G* basis with a
correlated CASPT2//CASSCF wave function has been investigated by comparing the excitation energies computed for
3-MIgas with ANO-S data from the literature (see Table 1). We
also recomputed the λfmax of the full models Mone-MD and ParvMD using the same ANO-S (C,N[4s3p1d]/H[2s]) basis set with
respect to the 6-31G* basis set. This yields a smaller blue-shifted
error (see Figure 2A and the Supporting Information) indicating
that, as expected, a better basis increases the computational
accuracy. However, since we focus on λfmax changes and to
avoid excessive computational costs, below we focus on the
6-31G* results.
Effect of the Fluorophore Environment. The limited,
relatiVe error in excitation energies computed for Mone-MD,
Parv-MD, and 3-MIgas prompts for an analysis of the factors
determining the λfmax values. Accordingly, the emission energy
of each model is compared with that of the isolated fluorophore
taken with its protein-optimized geometry (Figure 2B) and with
that of protein deprived of the solvent (Figure 2C).
Inspection of the data in Figure 2B shows that in Parv the
change in 3-MIfluor geometry cannot be responsible for the
observed red-shifted emission. In fact, the corresponding
3-MIfluor has an excitation energy that is only slightly higher
that the reference quantity (i.e., 3-MIgas). This is obviously due
to a limited protein-induced change in fluorophore excited state
geometry with respect to the gas phase. Such a conclusion is
confirmed by the data in Figure 3A pointing to a <0.015 Å
difference between the geometrical parameters of 3-MIgas and
of the Parv-MD fluorophore in both the ground and excited
states. Furthermore, the same quantity is close to the excitation
energy computed for the fluorophore of Parv in vacuo (see
Figure 2B) demonstrating that the solvent has a small effect on
the 3-MIfluor structure (see Figure 3A). This conclusion is further
supported by the data in Figure 2C where we show that removal
of the solvent from Parv-MD does not significantly change the
excitation energy (i.e., this value is very close to the excitation
energy of Parv in vacuo seen in Figure 2A).
In contrast to Parv, the data of Figure 2B show that, in Mone,
the isolated fluorophore must undergo a large structural change.
In fact, the corresponding excitation energy is significantly lower
with respect to 3-MIgas. Again, this is consistent with the
structure of Figure 3A that shows large deviations of the ground
state and excited state 3-MIfluor structures from the 3-MIgas
reference. Comparison of the Mone-MD excitation energies in
Figure 2A and 2B reveals that a decrease >50% of the excitation
energy with respect to 3-MIgas is due to a change in the
fluorophore structure. This change is very sensitive to the
structure of the solvent shell surrounding 3-MIfluor (or, in other
words, to the solvent average configuration model). Indeed, the
excitation energies of the Mone-MD and Mone shell fluorophores in Figure 2B are very different reflecting the limited
change in the structure of the Mone shell fluorophore with
respect to 3-MIgas (see Figure 3A). A correct solvent shell
configuration also induces the structural change that leads to
an enhanced dipole moment change and charge separation (see

Pistolesi et al.

Figure 3. (A) Ground (black) and 1La (red) equilibrium structure
parameters for 3-methylindole and the 3-methylindole fluorophore of
the Mone and Parv protein models. (B) Charge distribution of the
ground (S0) and excited (1La) state of 3-MIgas. Representative resonance
formulas are also displayed.

the Supporting Information). Comparison of the Mone data in
Figure 2A and 2C indicates that the point charges both of the
protein and of the solvent contribute, concurrently, to further
decrease the excitation energy of the Mone fluorophore. In
conclusion, the contributions of factor i and iii are not critical
for Parv but are both important when the fluorophore is in
contact with the solvent (as in Mone). The comparison between
the Mone-MD and Mone shell data in Figure 2B indicates that
the structure change of 3-MIfluor is due to factor iii.
A common basis for the discussion of the effects of the
protein residues and solvent molecules is provided by the charge
transfer nature of the spectroscopic state of tryptophan (see
Figure 3B for the case of 3-MIgas). In fact, in 3-MIgas 38% of
negative charge (π-electron density), originally located on the
pyrrole moiety, is shifted toward the benzene ring upon the
S0f1La transition. Thus, an electrostatic potential stabilizing the
positive charge on the 1La pyrrole moiety or stabilizing the
negative charge on the 1La benzene moiety will result in a
decreased 1LafS0 emission energy.40 Notice that while the 1La
equilibrium structure of the chromophore remains planar an
extensive bond length rearrangement occurs to accommodate
the charge transfer (see Figure 3A). As already mentioned above,
both the entity of the charge transfer and the bond readjustment
pattern are different in the systems investigated here. The Parv
fluorophore shows changes very close to those of 3-MIgas, while
as discussed above, in Mone these changes are different.
According to Figure 4A, the anisotropic electrostatic potential
(generated from the residue and solvent point charges) acting
on the chromophore centers of Parv-MD and Mone-MD is
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Figure 4. (A) Electrostatic potential on the carbon and nitrogen
3-MIfluor centers of Parv (Parv-MD model) and Mone (Mone-MD and
Mone shell models). Full circles indicate a negative (blue) or positive
(red) potential. (B) 3-MIfluor change in electrostatic potential for ParvMD and Mone-MD after removal of the Val43 and Lys44 residue
charges, respectively. Full triangles indicate changes toward negative
(tip down) and positive (tip up) values. On each structure, the numerical
values represent the highest and lowest values of the corresponding
quantity.

positive and localized on the benzene ring. This potential must
thus decrease the S1-S0 energy gap relative to the isolated
chromophore consistently with the computed λfmax red-shift. In
Parv, the electrostatic potential is due exclusively to the protein
charges.
Comparison of the Mone-MD and Mone shell electrostatic
potential in Figure 4A shows that this is very sensitive to the
configuration of the solvent shell surrounding 3-MIfluor. If this
configuration is not adapted to the protein and fluorophore
charges (i.e., does not correctly represent the average configuration of the solvent), the potential acting on the QM atoms is
negative and not positive. Consistently, with the excitation
energy and geometrical structure analysis given above, this
potential still leads to a (limited) red-shift since it is mainly
localized on the pyrrole unit where a positive charge developed
on the excited state (see Figure 3B).
Effect of Specific Residues and Solvent Molecules. To
assess the effect of specific side chains and water molecules,
we focus on the Parv-MD and Mone-MD models. As shown in
Figure 5A, Mone features a positively charged residue (Lys44)
in the close vicinity of the fluorophore. The effect of the Lys44
on the emission energy can be understood on the basis of the
charge transfer nature of the 1La state (see Figure 3B) and
position of the Lys44 chain. Since 1La features a more positive
pyrrole moiety and a more negative benzene ring with respect
to S0, the Lys44 charge, that is located on top of the benzene
moiety, must stabilize the excited state relative to the ground
state.
The electrostatic potential acting on the centers of the Mone
fluorophores in the absence of the Lys44 charges (Mone-Lys44)
is clearly less positive on the phenyl moiety and becomes very
negative on the pyrrole moiety (see Figure 4B). This unveils a
counterbalancing effect of Lys44 residue charges and solvent
shell. To explain this finding (i.e., a negative potential induced
by the removal of the positive Lys44 charge) one must focus
on the fact that in Mone the 3-MIfluor moiety and solvent shell
are adapted to the protein environments. Since the water
molecules have a large dipole moment their average orientation
will be determined by the interaction with the protein partial or

Figure 5. (A) Details of the region surrounding the fluorophore of
the computational models Parv-MD (left) and Mone-MD (right). The
configuration of the first solvent layer surrounding the Mone fluorophore
is displayed (see the Supporting Information for details). The closest
solvent molecule forms a hydrogen bond with the fluorophore N-H
group. For Parv, the relationship between the fluorophore (Trp102) and
one valine residue (Val43) is also given. The fluorophore is not in
contact with the solvent, and the closest solvent molecule is 6.28 Å
from the C2-H group of the fluorophore. (B) Analysis of the excitation
energies of Parv-MD (full circles) and Mone-MD (full squares) at the
corresponding 1La equilibrium structures. Each fragment is taken with
the geometry optimized for the full protein.

fully charged groups.14 Thus, in Mone, the positively charged
Lys44 residue, which, with respect to 3-MIfluor, is located
opposite to the solvent (see the right structure in Figure 5A),
will presumably orient the water molecules of the first solvation
shell (also through enhanced polarization of the fluorophore
π-system) in such a way to point their negatively charged
oxygens toward 3-MIfluor. This specific orientation leads to a
negative potential (with the largest intensity on the positively
charged pyrrole moiety). The 1La-S0 gap of the Mone-MDShell model with respect to Mone-MD indicates that only the
solvent molecules in the close vicinity of the fluorophore are
responsible for the described solvent effect and not the bulk.
In Figure 5B we report the results of an analysis of the effect
of selected residues and solvent molecules on the emission
maximum of the 3-MIfluor of Mone. It is apparent that the Lys44
residue has a red-shifting effect similar to that induced by the
full protein. It is also apparent that both the Lys44 residue alone
and a specific hydrogen bonded water molecule (linked to the
N-H bond of the pyrrole moiety) alone have similar red-shifting
effects on 3-MIfluor. It is interesting to see that when both effects
are present one still gets a similar red-shift pointing to a different
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The idea that the residues (or solvent molecules) in direct
contact or close to the chromophore/fluorophore control the
optical properties has also been investigated for the visual
photoreceptor rhodopsin.5 CASPT2//CASSCF/AMBER excitation energy computations demonstrate that only the residues in
the chromophore cavity affect significantly the excitation energy
and therefore the absorption wavelength.29 In our Parv model,
the electrostatic potential acting on the fluorophore is again
positive (see Figure 4B). Therefore, the effect of the hydrogenbonded Val43 residue must be such to increase the positive
potential at the level of the benzene moiety or decrease the
positive potential at the level of the indole moiety. As shown
in Figure 4B, removal of Val43 leads to a more negative
potential on the N-H region of indole. Thus, it is the latter
effect to occur in Parv.
Conclusions

Figure 6. Comparison between predicted emission wavelength redshift (with respect to in vacuo 3-MI) for Parv and Mone using ab initio
CASPT2//CASSCF/AMBER (this paper) and the semiempirical INDO/
S-CIS/CHARMM QM/MM protocols (see ref 14). The white and black
horizontal bars represent the wavelength change induced by the solvent
or protein charges, respectively (e.g., the black bars in Parv-MD and
Mone-MD correspond to the data of Figure 2C).

and opposite sign of the electrostatic potential projected on the
chromophore. Because of the different sign of the potential, the
stabilizing effects partially cancel each other. This seems in line
with the picture given above on the basis of the potentials of
Figure 4. On the other hand, it is clear that other residues such
as, for instance, Lys43 must contribute to the total red-shift with
respect to bare 3-MIfluor. As shown in Figure 5B, this effect is
smaller due to the largest distance of this residue from the phenyl
moiety.
In conclusion, from a mechanistic point of view, our analysis
unveils that the dipole of one N-H hydrogen-bonded water
molecule and the positive charge of the Lys44 residue are mainly
responsible for the low emission energy of tryptophan in Mone.
The water dipole stabilizes the positive charge on the pyrrole
moiety, while the Lys44 residue stabilizes the negative charge
on the benzene moiety of the 1La state of 3-MIFluor. This analysis
reveals the complex origin of the total electrostatic potential
that cannot be disentangled in simple additional contributions.
A similar analysis can be carried out for Parv. In this case,
we detected a large effect (a ≈2 kcal mol-1 red-shift) associated
with the Val43 residue of the fluorophore cavity. The remaining
cavity residues have, taken individually, a much smaller effect.
However, as shown in Figure 5B (see the “Full Protein-Val43”
value), these induce, cooperatively, a ≈3 kcal mol-1 red-shift.
The origin of the Val43 effect has been determined by inspection
of the 1La structure of Parv reported in Figure 5A (left). From
such a structure, it is apparent that the backbone carbonyl group
of Val43 points toward the N-H group of 3-MIFluor and forms
a hydrogen bond. Thus, the computed decrease in emission
energy originates from a stabilization of the positive charge on
the pyrrole ring that, in turn, induces a stabilization of the excited
state with respect to the ground state. Once again, the decomposition of the solvated Parv suggests that the external solvent
does not play a key role in controlling λfmax. Such control is
due to the residues in the fluorophore cavity.

The work of Callis and co-workers14 has established that a
QM/MM protocol based on semiempirical quantum chemical
methods and a suitable fluorophore charge scaling can successfully reproduce the fluorescence maxima of 19 tryptophancontaining proteins with a ≈15 nm error. In that study, all
protein-solvent systems (with a fixed 1La reference geometry
for the fluorophore moiety) were modeled via a 30 ps trajectory
and the emission maxima determined by averaging the emission
energies of many snapshots. While such a protocol cannot be
used with state-of-the-art ab initio QM methods, in the past we
have provided evidence that both absorption and emission can
be simulated using the CASPT2//CASSCF/AMBER protocol.
In particular, using a crystallographic structure and a suitably
prepared solvent box to model the average protein-solvent
environment,6,7 it has been shown that the absorption or
fluorescence of anionic and cationic biological chromophores/
fluorophores can be reproduced within <5 kcal mol-1.
Above, the CASPT2//CASSCF/AMBER protocol has been
used to study the spectroscopy of two very different proteinembedded tryptophans as examples of neutral biological fluorophores. As shown in Figure 2, and in spite of the absence of
empirical parameters, the ab initio CASPT2//CASSCF level
allows us to reproduce the observed changes in λfmax value (i.e.,
with respect to 3-MI) with errors smaller than those obtained
using not scaled semiempirical methods. Most important, the
error is of the same magnitude as that found in proteins
containing charged chromophores. Therefore, our study extends
the validity of the protocol and paves the way to first-principle
simulations of the photophysics of protein-embedded fluorescent
probes.
We believe that the results presented above will have an
impact on future studies of the fluorescence lifetime and decay
dynamics of tryptophan. Indeed, previous mechanistic studies
of the fluorescence decay dynamics of synthetic fluorophores
demonstrate that the decay may occur via aborted chemical or
electron transfer reactions mediated by conical intersection
channels. This fact calls for the use of multiconfigurational
quantum chemical theories (e.g., CASSCF) where real (nonavoided) crossings between potential energy surfaces of the same
spin multiplicity are properly represented.34-36
Consistently with previous work, we have confirmed that in
Parv the environmental effects on the λfmax value are mainly
due to stabilization of the emitting charge-transfer state. On the
other hand, it has been possible to unveil that, in contrast to
semiempirical studies,14 the ab initio CASPT2//CASSCF treatment points to a minor effect of the external solvent on the
λfmax change when a fluorophore is embedded in a substantially
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hydrophobic protein matrix. In contrast, we have shown that
when the fluorophore is in contact with the solvent (e.g., in
Mone) the solvent contribution to the λfmax change is very
important and also affects the fluorophore structure.
The red-shift values induced by the protein and solvent
charges are summarized in Figure 6. For Parv, the computed
CASPT2//CASSCF/AMBER and “scaled-charge” INDO/S-CIS/
CHARMM emission shifts have very different magnitudes. In
fact, the semiempirical data point to a large and dominating
effect of the solvent surrounding the protein (i.e., not in contact
with 3-MIfluor). In contrast, the ab initio data point to a
dominating effect of the protein (consistently with the red-shift
value of the Parv in vacuo unsolvated model). On the other
hand, for Mone, the ratio between the solvent and protein effects
is more balanced. However, in this case the INDO/S-CIS/
CHARMM emission points to a protein dominating effect, while
the CASPT2//CASSCF/AMBER protocol yields a solvent effect
that is larger that the protein effect. Of course, as shown in the
figure (see full model bars), these effects are far from being
additive as the electrostatic field imposed by the solvent is
modified by that of the protein, and this depends on the protein
and solvent spatial locations with respect to the fluorophore.
At least three of the specific i-iv factors mentioned above
have been found to affect the fluorescence color in Mone and
Parv. The first mechanism corresponds to factor i. In fact, in
Mone, the bond-length pattern of 3-MIfluor is very different from
that of the reference gas-phase fluorophore. It seems that the
change is induced by the solvent shell structure. A second
important factor is factor ii. This is related to the effect of
specific and strategically located protein cavity residues. In
Mone, the Lys44 residue with its positive charge placed above
the benzene moiety and in Parv the Val43 residue that forms
hydrogen bonds with the pyrrole moiety of the fluorophore
constitute clear examples. The impact of specific interactions
is estimated of the order of 2 kcal mol-1 (see Figure 5B). Of
course, cooperative effects in the same category (i.e., contributions coming from many fractional charges) may have a
considerable weight. The third mechanism is related to the direct
electrostatic interaction with the solvent and corresponds to
factor iii. It is found that this factor is coupled with factor i and
ii. In fact, in Mone both the fluorophore π-system polarization
and the geometrical reorganization of the first solvent shell seem
to account for part of the red-shifting effect. On the other hand,
interactions with specific solvent molecules (e.g., a single water
molecule in Mone) account for the emission energy decrease.
In the near future, the development of accurate tools for the
simulation of the changes in tryptophan fluorescence and
fluorescence lifetimes as a function of the residue position in a
peptide backbone may constitute one important tool for the
design of unnatural proteins with wanted properties. These tools
will have to be potent enough to be able to describe the
mechanism of internal residue or solvent mediated quenching.
In particular, they should be able to deal with large and rapid
changes in the structure and electronic wave function that often
characterize photoinduced aborted photochemical or electron
transfer reactions. Presently, it is accepted that these processes
imply the evolution toward a conical intersection funnel
connecting the emitting excited state to the ground state or to
a lower nonemitting excited state (e.g., conical intersections are,
by definition, regions of rapid change in electronic structure).
The investigation of these processes calls for unbiased quantum
chemical methods featuring highly flexible wave functions and
for the tools of the emerging field of computational photochemistry.33 Above we have provided evidence that, for two very
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different proteins, the use of QM/MM strategy based on
multiconfigurational second-order perturbation theory can potentially give access to a quantitative mapping of the excited
state reaction paths and, in turn, resolve the atomic-level
mechanism controlling the fluorescence quenching/decay.9,11-13,41
Recent work has established that the evaluation of realistic time
scales (including the biexponential character of such processes42)
via scaled-CASSCF/AMBER trajectories is becoming a reality.37
Given the steady increase in computer performances, the
continuation of such exploratory research effort, in our and other
laboratories, appears to open new perspectives for the future of
de novo light-sensitive protein design.
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